tirzepatide clinical trial weight loss results UC Irvine researchers project cardiac benefits from weight-loss medication Before and after tirzepatide weight

Dose titration plays an important role in managing side effects

Small, nutrient-dense meals are often easier than large portions when appetite is suppressed

Weight loss results In a 2022 review of 22 studies that included more than 17,000 people with or without type 2 diabetes treated with semaglutide or liraglutide: More than 50% of participants treated with either semaglutide or liraglutide lost 5% or more of their starting weight after an average of 39 weeks on the medicine About 17% of participants lost 10% or more of their body weight in the same period A phase 3 clinical trial studied treatment with tirzepatide in people with obesity and found that it produced substantial and sustained weight loss at various dose strengths

The 1ml option works well for experienced users who need smaller injection volumes or are on higher doses

Changing injection sites each week helps reduce the risk of skin thickening and lumps